T-cure 0.02 is a Product of the Generic Naftifine Hydrochloride

T-cure 0.02 belongs to the generic category of Naftifine Hydrochloride. This medicine should be used according to a doctor's advice. We have provided detailed information about the uses, dosage, effectiveness, side effects, precautions, drug interactions, storage conditions, and other important details of T-cure 0.02. Our goal is to present essential medicine information in one place for patients, caregivers, and healthcare professionals. To better understand Naftifine Hydrochloride and ensure the safe use of this medicine, please read the information below carefully and consult a healthcare professional when necessary.

Description of T-cure 0.02

T-cure 0.02 may be available as a prescription or over-the-counter medicine, depending on local regulations and medical recommendations. It is used for the treatment and management of specific conditions or symptoms. The way this medicine is used may vary depending on the patient's condition and the advice of a healthcare provider. Detailed information about the approved uses, therapeutic applications, and other relevant details of T-cure 0.02 is provided below to help users gain a clear understanding of this medicine.

What Is T-cure 0.02 Indications and Uses?

Naftifine cream is an allylamine antifungal indicated for the treatment of interdigital tinea pedis, tinea cruris, and tinea corporis caused by the organism Trichophyton Rubrum.

Pharmacology (Source, Chemical and Physical Composition) Of T-cure 0.02

The exact mechanism of action against fungi is not known, Naftifine Hydrochloride appears to interfere with sterol biosynthesis by inhibiting the enzyme squalene 2, 3-epoxidase. This inhibition of enzyme activity results in decreased amounts of sterols, especially ergosterol and a corresponding accumulation of squalene in the cells.

Dosage And Administration of T-cure 0.02

Apply a thin layer of Naftifine Hydrochloride Cream once-daily to the affected areas plus half inch margin of healthy surrounding skin for 2 weeks or as directed by the physician.Use in Children and Adolescents: The safety and effectiveness of Naftifine Hydrochloride have been establishedin the age group of 12-17 years with interdigital tinea pedis and tinea cruris.

Drug Interactions of T-cure 0.02

No information is available.

Side Effects of T-cure 0.02

The most common adverse reaction (≥1%) is pruritus.

Use During Pregnancy and Lactation

Pregnancy Category B. There are no adequate and well-controlled studies of Naftifine Cream in pregnant women. Because animal reproduction studies are not always predictive of human response, Naftifine Cream should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk, caution should be exercised when Naftifine Cream is administered to a nursing woman.

Precautions And Warnings for T-cure 0.02

If irritation or sensitivity develops with the use of Naftifine Hydrochloride Cream, treatment should be discontinued.

Therapeutic Class

Topical Antifungal preparations

Storage Conditions of It

Store below 30°C, away from light and in a dry place. Keep out of the reach of children.

T-cure 0.02 is a Product of the Generic Naftifine Hydrochloride

T-cure 0.02

Incepta Pharmaceuticals Ltd. · Cream

Naftifine Hydrochloride